Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation (Q46104700)

19 December 2017

title

Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation (English)

1 reference

19 December 2017

1 reference

Cristina Marta Del-Ben

2

1 reference

19 December 2017

author name string

C Garcia-Leal

1

1 reference

19 December 2017

F M Leal

3

1 reference

19 December 2017

F G Graeff

4

1 reference

19 December 2017

F S Guimarães

5

1 reference

19 December 2017

language of work or name

English

0 references

publication date

27 February 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

683-694

1 reference

19 December 2017

Low-dose citalopram as a 5-HT neuroendocrine probe

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Acute citalopram administration produces correlated increases in plasma and salivary cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A single dose of citalopram increases fear recognition in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Stereoisomers in Psychiatry: The Case of Escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Anxiolytic-Like Effects of Escitalopram, Citalopram, and R-Citalopram in Maternally Separated Mouse Pups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A comparison of d, l-fenfluramine and citalopram challenges in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Social phobia in the general population: prevalence and sociodemographic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Does the panic attack activate the hypothalamic-pituitary-adrenal axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Role of 5-HT in stress, anxiety, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Pharmacology of human experimental anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Effect of metergoline on human anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Ritanserin facilitates anxiety in a simulated public-speaking paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Acute SSRI administration affects the processing of social cues in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Effects of oral racemic citalopram on neuroendocrine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Coronary vasoconstriction induced by mental stress (simulated public speaking).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Modulation of anxiety circuits by serotonergic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Simulated public speaking as a model of clinical anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The action of sedatives on brain stem oculomotor systems in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Selective serotonin reuptake inhibitors and neuroendocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The clinical pharmacokinetics of escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

A panic attack-like unusual stress reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Ethnic differences in hemodynamic responses to stress in hypertensive men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Opposite effects of nefazodone in two human models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Hormonal probes of central serotonergic activity: do they really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Spontaneous activity of dorsal raphe neurons during defensive and offensive encounters in the tree-shrew.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108101782

21 January 2018

Identifiers

DOI

10.1177/0269881108101782

1 reference

19 December 2017

PubMed ID

19251828

1 reference

19 December 2017